Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
A PheWAS approach in studying HLA-DRB1*1501.
The Immune Pathogenesis of Multiple Sclerosis.
M. paratuberculosis Heat Shock Protein 65 and Human Diseases: Bridging Infection and Autoimmunity.
The clinical overlap of multiple sclerosis and headache.
B-Cell Targeting Agents in the Treatment of Multiple Sclerosis.
Does levetircetam decrease of the rubral tremor in patients with multiple sclerosis.
β-Arrestins 1 and 2 are critical regulators of inflammation.
Acute bilateral visual loss in a young adult.
Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice.
Immunotherapy of Neuromyelitis Optica.
Isoprostanes in clinically isolated syndrome and early multiple sclerosis as biomarkers of tissue damage and predictors of clinical course.
Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Glia in the pathogenesis of neurodegenerative diseases.
Association between age at onset of multiple sclerosis and vitamin D level-related factors.
Role of Chlamydia in Multiple Sclerosis.
[Neuropathology of multiple sclerosis].
Brain-derived neurotrophic factor and its clinical implications.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
MS risk allele rs1883832T is associated with decreased mRNA expression of CD40.
Acute Disseminated Encephalomyelitis in a Child Following Plasmodium vivax Malaria.
RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Pages
« first
‹ previous
…
363
364
365
366
367
368
369
370
371
…
next ›
last »